Voloridge Investment Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $104M | Sell |
438,127
-127,006
| -22% | -$26.4M | 0.44% | 45 |
|
|
2026
Q1 | $119M | Sell |
565,133
-86,745
| -13% | -$18.7M | 0.48% | 37 |
|
|
2025
Q4 | $134M | Sell |
651,878
-115,836
| -15% | -$21.8M | 0.47% | 32 |
|
|
2025
Q3 | $121M | Buy |
767,714
+105,841
| +16% | +$16.3M | 0.4% | 47 |
|
|
2025
Q2 | $111M | Sell |
661,873
-675,499
| -51% | -$100M | 0.41% | 46 |
|
|
2025
Q1 | $184M | Buy |
1,337,372
+31,354
| +2% | +$4M | 0.68% | 8 |
|
|
2024
Q4 | $154M | Sell |
1,306,018
-179,067
| -12% | -$20.9M | 0.55% | 24 |
|
|
2024
Q3 | $164M | Buy |
1,485,085
+79,184
| +6% | +$8.28M | 0.6% | 19 |
|
|
2024
Q2 | $138M | Buy |
1,405,901
+366,502
| +35% | +$37.3M | 0.51% | 27 |
|
|
2024
Q1 | $116M | Buy |
1,039,399
+103,084
| +11% | +$11.1M | 0.42% | 48 |
|
|
2023
Q4 | $94.4M | Buy |
936,315
+531,587
| +131% | +$52.7M | 0.37% | 66 |
|
|
2023
Q3 | $35.1M | Buy |
404,728
+379,530
| +1,506% | +$34.3M | 0.17% | 162 |
|
|
2023
Q2 | $2.38M | Buy |
+25,198
| New | +$2.13M | 0.01% | 933 |
|
|
2023
Q1 | – | Sell |
-372,623
| Closed | -$28.6M | – | 1380 |
|
|
2022
Q4 | $28.6M | Sell |
372,623
-370,336
| -50% | -$28.1M | 0.16% | 189 |
|
|
2022
Q3 | $49.5M | Buy |
742,959
+518,529
| +231% | +$32.9M | 0.27% | 84 |
|
|
2022
Q2 | $11.7M | Buy |
224,430
+48,383
| +27% | +$2.75M | 0.06% | 394 |
|
|
2022
Q1 | $9.98M | Sell |
176,047
-688,052
| -80% | -$36.8M | 0.06% | 406 |
|
|
2021
Q4 | $44.5M | Buy |
864,099
+589,400
| +215% | +$28.9M | 0.24% | 95 |
|
|
2021
Q3 | $13.6M | Buy |
274,699
+234,902
| +590% | +$12.7M | 0.09% | 318 |
|
|
2021
Q2 | $2.27M | Sell |
39,797
-6,962
| -15% | -$407K | 0.02% | 949 |
|
|
2021
Q1 | $2.84M | Buy |
46,759
+40,992
| +711% | +$2.26M | 0.02% | 688 |
|
|
2020
Q4 | $309K | Sell |
5,767
-68,378
| -92% | -$3.55M | ﹤0.01% | 1217 |
|
|
2020
Q3 | $3.48M | Buy |
+74,145
| New | +$3.8M | 0.03% | 548 |
|
|
2020
Q2 | – | Sell |
-52,482
| Closed | -$2.52M | – | 1269 |
|
|
2020
Q1 | $2.52M | Sell |
52,482
-7,047
| -12% | -$366K | 0.07% | 296 |
|
|
2019
Q4 | $3.01M | Sell |
59,529
-1,974
| -3% | -$102K | 0.06% | 395 |
|
|
2019
Q3 | $2.9M | Buy |
+61,503
| New | +$2.81M | 0.05% | 360 |
|
|
2019
Q1 | – | Sell |
-17,805
| Closed | -$794K | – | 939 |
|
|
2018
Q4 | $794K | Sell |
17,805
-139,389
| -89% | -$7.27M | 0.04% | 294 |
|
|
2018
Q3 | $8.49M | Buy |
+157,194
| New | +$8.04M | 0.18% | 121 |
|
|
2016
Q2 | – | Sell |
-42,945
| Closed | -$3.52M | – | 306 |
|
|
2016
Q1 | $3.52M | Buy |
+42,945
| New | +$3.49M | 0.08% | 166 |
|
Other funds holding CAH
Voloridge Investment Management's CAH Position: Q2 2026 in Review
Voloridge Investment Management reduced its Cardinal Health (CAH) stake by 22% in Q2 2026, selling an estimated $26.4M and leaving 438,127 shares worth $104M. The position accounts for 0.44% of the portfolio, ranked #45.
Voloridge Investment Management first reported a position in CAH in Q1 2016 and has held it in 29 quarters since. The position peaked at $184M in Q1 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Voloridge Investment Management held 438,127 shares of Cardinal Health worth $104M as of Q2 2026.
- Voloridge Investment Management sold 127,006 Cardinal Health shares in Q2 2026, an estimated $26.4M.
- Cardinal Health made up 0.44% of Voloridge Investment Management's portfolio in Q2 2026, its #45 holding.
- Voloridge Investment Management first reported a position in Cardinal Health in Q1 2016 and has held it in 29 quarters since.
- Voloridge Investment Management's Cardinal Health position peaked at $184M in Q1 2025.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.